# Bone Biologics Corp: Form 10-Q for the period ended Sep 30, 2021

- Company: [Bone Biologics Corp](/companies/bblg.md) (CIK 1419554)
- Form: 10-Q
- Filed: 2021-11-15
- Accepted by EDGAR: Nov 15, 2021, 12:38 ET
- Period: 2021-09-30
- Accession: 0001493152-21-028429
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1419554/000149315221028429/form10-q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1419554/000149315221028429/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2021-09-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Research and development | 9 months, 2021-01-01 to 2021-09-30 | $47.5k | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months, 2021-07-01 to 2021-09-30 | −$229.8k | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2021-01-01 to 2021-09-30 | −$642.6k | us-gaap:OperatingIncomeLoss |
| Net income | 3 months, 2021-07-01 to 2021-09-30 | −$509.3k | us-gaap:NetIncomeLoss |
| Net income | 9 months, 2021-01-01 to 2021-09-30 | −$1.4m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2021-07-01 to 2021-09-30 | −$0.17 | us-gaap:EarningsPerShareBasicAndDiluted |
| Diluted EPS | 9 months, 2021-01-01 to 2021-09-30 | −$0.49 | us-gaap:EarningsPerShareBasicAndDiluted |
| Operating cash flow | 9 months, 2021-01-01 to 2021-09-30 | −$1.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Cash and equivalents | at 2021-09-30 | $3.4k | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Total assets | at 2021-09-30 | $52.4k | us-gaap:Assets |
| Total liabilities | at 2021-09-30 | $15.2m | us-gaap:Liabilities |
| Shareholders' equity | at 2021-09-30 | −$15.1m | us-gaap:StockholdersEquity |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1419554/000149315221028429/form10-q.htm

Filed Nov 15, 2021.
Source: SEC EDGAR, the filing index for accession 0001493152-21-028429. Last ingested by Listed: Nov 11, 2026, 03:46 ET. No prices; not investment advice.
